Gregory Bailey - Net Worth and Insider Trading
Gregory Bailey Net Worth
The estimated net worth of Gregory Bailey is at least $192 Million dollars as of 2024-11-05. Gregory Bailey is the Director of Biohaven Ltd and owns about 1,620,071 shares of Biohaven Ltd (BHVN) stock worth over $82 Million. Gregory Bailey is the Director of Medivation Inc and owns about 894,660 shares of Medivation Inc (MDVN) stock worth over $73 Million. Gregory Bailey is also the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. Besides these, Gregory Bailey also holds Serina Therapeutics Inc (SER) . Details can be seen in Gregory Bailey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory Bailey has not made any transactions after 2024-09-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gregory Bailey
Gregory Bailey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory Bailey owns 5 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , AgeX Therapeutics Inc (AGE) , and Medivation Inc (MDVN) among others .
Click here to see the complete history of Gregory Bailey’s form 4 insider trades.
Insider Ownership Summary of Gregory Bailey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2022-08-19 | director |
| AGE | AgeX Therapeutics Inc | 2018-11-27 | director |
| MDVN | Medivation Inc | 2012-10-30 | director |
 | | 2006-04-13 | director |
| | 2024-09-24 | director |
Gregory Bailey Latest Holdings Summary
Gregory Bailey currently owns a total of 4 stocks. Among these stocks, Gregory Bailey owns 1,620,071 shares of Biohaven Ltd (BHVN) as of September 24, 2024, with a value of $82 Million and a weighting of 42.85%. Gregory Bailey owns 894,660 shares of Medivation Inc (MDVN) as of October 24, 2012, with a value of $73 Million and a weighting of 37.98%. Gregory Bailey also owns 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of August 19, 2022, with a value of $36 Million and a weighting of 18.96%. The other 1 stocks Serina Therapeutics Inc (SER) have a combined weighting of 0.21% among all his current holdings.
Latest Holdings of Gregory Bailey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd | 2024-09-24 | 1,620,071 | 50.75 | 82,218,603 |
| MDVN | Medivation Inc | 2012-10-24 | 894,660 | 81.44 | 72,861,110 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2022-08-19 | 2,583,658 | 14.08 | 36,377,905 |
| SER | Serina Therapeutics Inc | 2024-09-20 | 63,377 | 6.29 | 398,641 |
Holding Weightings of Gregory Bailey
Gregory Bailey Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory Bailey has made a total of 6 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 5,000 shares on September 24, 2024, which cost Gregory Bailey around $220,950.
According to the SEC Form 4 filings, Gregory Bailey has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 33,600 shares on October 24, 2012, which brought Gregory Bailey around $900,480.
According to the SEC Form 4 filings, Gregory Bailey has made a total of 7 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 38,000 shares on August 19, 2022, which cost Gregory Bailey around $6 Million.
More details on Gregory Bailey's insider transactions can be found in the Insider Trading History of Gregory Bailey table.Insider Trading History of Gregory Bailey
- 1
Gregory Bailey Trading Performance
GuruFocus tracks the stock performance after each of Gregory Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Bailey is 9.29%. GuruFocus also compares Gregory Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Bailey within 3 months outperforms 5 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory Bailey's insider trading performs compared to the benchmark.
Performance of Gregory Bailey
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.52 | | | | | |
| Relative Return to S&P 500(%) | 0.98 | | | | | |
Gregory Bailey Ownership Network
Ownership Network List of Gregory Bailey
Ownership Network Relation of Gregory Bailey
Gregory Bailey Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Gregory Bailey is the director of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Gregory Bailey Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory Bailey. You might contact Gregory Bailey via mailing address: 4 A Chesham Street, London X0 Sw1x8dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
